TITLE

Experience in Monitoring Gentamicin Therapy during Treatment of Serious Gram-Negative Sepsis

AUTHOR(S)
Noone, P.; Parsons, T. M. C.; Pattison, J. R.; Slack, R. C. B.; Garfield-Davies, D.; Hughes, K.
PUB. DATE
March 1974
SOURCE
British Medical Journal;3/16/1974, Vol. 1 Issue 5906, p477
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64109833

 

Related Articles

  • Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly. Triggs, E.; Charles, B. // Clinical Pharmacokinetics;1999, Vol. 37 Issue 4, p331 

    Gentamicin is frequently used in elderly patients as serious infection, particularly Gram-negative bacilli, remains one of the major health problems experienced by this age group. A number of physiological changes in drug disposition occur with ageing and potentially these can affect gentamicin...

  • Neurosurgical Gram-Negative Bacillary Ventriculitis and Meningitis: A Retrospective Study Evaluating the Efficacy of Intraventricular Gentamicin Therapy in 31 Consecutive Cases. Tängdén, Thomas; Enblad, Per; Ullberg, Måns; Sjölin, Jan // Clinical Infectious Diseases;6/1/2011, Vol. 52 Issue 11, p1310 

    Background. Gram-negative bacillary (GNB) ventriculitis and meningitis are rare but serious complications after neurosurgery. Prospective studies on antibiotic treatment for these infections are lacking, and retrospective reports are sparse. At our hospital in Uppsala, Sweden, meropenem has been...

  • Antibiotic susceptibility of isolates from paediatric intensive care units in Zagreb. Bedenić, Branka; Prahin, Esmina; Vranić-Ladavac, Mirna; Atalić, Vlasta; Sviben, Mario; Frančula-Zaninović, Šonja; Plećko, Vanda; Kalenić, Smilja // Medicinski Glasnik;Feb2014, Vol. 11 Issue 1, p72 

    Aim Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Program is a longitudinal global surveillance study to monitor in vitro data on microbial susceptibility in centers that prescribe meropenem. Results of the six years period (2002-2007) for the antimicrobial efficacy of...

  • Treatment of Gram--Negative Bacillary Meningitis in Adults. Rahal Jr., James J. // Annals of Internal Medicine;Aug72, Vol. 77 Issue 2, p295 

    Provides information on the treatment of Gram-negative bacillary meningitis, associated with the central nervous system. Application of antimicrobial therapy in Gram-negative activity; Utilization of kanamycin and gentamicin as treatment for the condition; Effect of antibiotics on the central...

  • COST OF THERAPEUTIC DRUG MONITORING -- A PRELIMINARY STUDY. Ahmed, Hisham E.; Ab Rahman, Ab Fatah; Mohamed Ibrahim, Mohamed Izham // Malaysian Journal of Medical Sciences;Jan2007 Supplement, Vol. 14, p154 

    Introduction: In an attempt to minimize the hospital medical care costs, we conducted a study to calculate the cost of providing Therapeutic Drug Monitoring (TDM) service for hospitalized patients with bronchopneumonia in Hospital Universiti Sains Malaysia (HUSM). Methodology: Data of adult...

  • Profile of Neonatal Septicaemia at a District-level Sick Newborn Care Unit. Viswanathan, Rajlakshmi; Singh, Arun K.; Ghosh, Chiranjib; Dasgupta, Sudipta; Mukherjee, Suchandra; Basu, Sulagna // Journal of Health, Population & Nutrition;Mar2012, Vol. 30 Issue 1, p41 

    Although sepsis is a major cause of morbidity and mortality among newborns in resource-poor countries, little data are available from rural areas on culture-proven sepsis. The aim of the present study was to provide information in this regard. The study reports results on the incidence and...

  • Kaleidoscope. Ely, E. Wesley // Annals of Internal Medicine;1/20/2015, Vol. 162 Issue 2, p152 

    A personal narrative is presented which explores the author's experience of treating various patients with serious diseases such as gram-negative sepsis complicating peritoneal dialysis, pulmonary fibrosis, and nonalcoholic steatohepatitis.

  • tobramycin.  // Royal Society of Medicine: Medicines;2002, p538 

    This article provides information on tobramycin, an antibacterial and antibiotic drug of the aminoglycoside group. The drug is effective against some Gram-positive and Gram-negative bacteria and is used primarily for the treatment of serious Gram-negative infections caused by Pseudomonas...

  • Gram-Negative Rod Bacteremia: Microbiologic, Immunologic, and Therapeutic Considerations. Young, Lowell S.; Martin, William J.; Meyer, Richard D.; Weinstein, Ralph J.; Anderson, Elizabeth T. // Annals of Internal Medicine;Apr77, Vol. 86 Issue 4, p456 

    Discusses the diagnosis and treatment of Gram-negative rod bacteremia, a leading infectious disease problem in American hospitals during 1970s. Blood cultures and the microbiology of the bacteremia; Neutrophil function in Gram-negative rod baceremia; Antimicrobial therapy of the disease; Effect...

  • Neonatal septicaemia: prevalence and antimicrobial susceptibility patterns of common pathogens at Princess Marina Hospital, Botswana. Mudzikati, Lydia; Dramowski, Angela // Southern African Journal of Infectious Diseases;2015, Vol. 30 Issue 3, p108 

    Background: Septicaemia is the third most common cause of neonatal death after prematurity and birth asphyxia. The prevalence of neonatal sepsis and the spectrum of causative microorganisms fluctuates over time, thus facility-specific surveillance of neonatal bloodstream infections is important....

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics